Xaira Therapeutics Stock
HealthTechLooking to sell Xaira Therapeutics stock or options?
Xaira Therapeutics is dedicated to developing life-changing medicines by harnessing the transformative power of artificial intelligence. The company focuses on creating computational methods, models, data sets, platforms, and processes that enhance the ability of science to cure disease. Through these innovative approaches, Xaira Therapeutics empowers patients by developing novel therapeutics designed to address their medical needs.
Rsquared, Longwood Fund, Foresite Capital, Two Sigma Ventures, WRF Capital, Sequoia Capital, ARCH Venture Partners, F-Prime Capital, Lux Capital, Foresite Labs, Breyer Capital, New Enterprise Associates, Menlo Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, SV Angel, Alternative Investment Management.